#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3490	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2441	420.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	1910	1910	T	488	T,G,A	400,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3490	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2441	420.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1644	1644	C	551	C,T	436,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5670	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3807	445.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1705	1705	A	474	A,G	392,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5670	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3807	445.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2339	2339	C	532	C,A	434,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5670	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3807	445.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2413	2413	A	561	A	435	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5670	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3807	445.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2965	2965	C	528	C,A	424,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	0	.	p	.	0	Q7R	NONSYN	19	21	CAG	513	515	CGG	72;72;72	C;G;G	59;59;55	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	0	.	p	.	0	V36A	NONSYN	106	108	GTG	600	602	GCG	71;70;70	G;C;G	57;59;59	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	642	644	CGG	65;65;65	C,T;G;G	53,1;58;55	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	0	.	p	.	0	S68A	NONSYN	202	204	TCG	696	698	GCG	73;73;73	G;C;G	55;54;57	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	0	.	p	.	0	I96V	NONSYN	286	288	ATC	780	782	GTC	76;76;76	G;T,G;C	53;53,1;53	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	0	.	p	.	0	N125T	NONSYN	373	375	AAT	867	869	ACC	78;79;80	A;C;C	59;59;61	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	0	.	p	.	0	K151E	NONSYN	451	453	AAA	945	947	GAA	78;77;76	G;A;A	63;62;62	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	0	.	p	.	0	T152N	NONSYN	454	456	ACC	948	950	AAC	76;76;77	A;A;C	61;63;61	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	0	.	p	.	0	A172T	NONSYN	514	516	GCG	1008	1010	ACA	66;66;66	A,C;C;A	55,1;57;60	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	0	.	p	.	0	A175E	NONSYN	523	525	GCG	1017	1019	GAA	68;68;68	G;A,C;A	58;57,1;56	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	0	.	p	.	0	E176T	NONSYN	526	528	GAA	1020	1022	ACC	67;67;67	A;C;C	55;59;59	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	0	.	p	.	0	I178V	NONSYN	532	534	ATC	1026	1028	GTC	68;67;68	G;T;C	60;55;57	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	0	.	p	.	0	I188T	NONSYN	562	564	ATA	1056	1058	ACG	65;64;64	A;C;G	56;54;52	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	0	.	p	.	0	P200N	NONSYN	598	600	CCC	1092	1094	AAC	64;63;62	A,G;A;C	49,1;49;48	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1152	1154	TTG	65;65;65	T;T;G	52;48;53	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1209	1211	ACC	65;65;66	A;C;C	51;47;52	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1212	1214	GAC	66;66;66	G;A;C	52;50;50	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1221	1223	GCG	66;66;67	G;C;G	52;56;55	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1257	1259	GCT	62;62;62	G;C;T	52;52;52	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	0	.	p	.	0	Q261K	NONSYN	781	783	CAA	1275	1277	AAA	62;62;62	A,C;A;A	52,1;52;48	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	308	folP	858	858	91.49	folP.l15.c4.ctg.1	1817	50.7	1	SNP	p	R230S	1	.	.	688	690	AGC	1182	1184	AGC	62;62;62	A;G;C	48;48;49	folP.Neisseria_meningitidis_MC58_v2_01707:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1044	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3644	85.2	1	SNP	p	S91F	0	.	.	271	273	TCC	665	667	TCC	87;87;87	T;C;C	70;70;73	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1044	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3644	85.2	1	SNP	p	D95G	0	.	.	283	285	GAC	677	679	GAC	82;82;82	G,T;A;C,T	66,1;66;69,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1044	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3644	85.2	1	SNP	p	D95N	0	.	.	283	285	GAC	677	679	GAC	82;82;82	G,T;A;C,T	66,1;66;69,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	430	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1758	73.4	1	SNP	p	G45D	1	.	.	133	135	GAC	687	689	GAC	120;120;120	G;A;C	96;93;99	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	270	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1333	60.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1054	parC	2304	2304	98.31	parC.l15.c4.ctg.1	3179	98.9	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1689	1691	GCA	130;131;131	G;C;A	101;101;106	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1054	parC	2304	2304	98.31	parC.l15.c4.ctg.1	3179	98.9	0	.	p	.	0	A521T	NONSYN	1561	1563	GCC	1947	1949	ACC	108;107;107	A;C;C	87;89;92	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1054	parC	2304	2304	98.31	parC.l15.c4.ctg.1	3179	98.9	0	.	p	.	0	S575L	NONSYN	1723	1725	TCG	2109	2111	TTG	105;107;106	T;T;G	84;85;84	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1054	parC	2304	2304	98.31	parC.l15.c4.ctg.1	3179	98.9	0	.	p	.	0	S580T	NONSYN	1738	1740	TCG	2124	2126	ACA	107;107;107	A,C;C;A	80,1;84;80	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1054	parC	2304	2304	98.31	parC.l15.c4.ctg.1	3179	98.9	0	.	p	.	0	I581L	NONSYN	1741	1743	ATC	2127	2129	CTC	107;107;109	C;T;C	85;85;87	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1054	parC	2304	2304	98.31	parC.l15.c4.ctg.1	3179	98.9	0	.	p	.	0	G635A	NONSYN	1903	1905	GGC	2289	2291	GCT	102;102;101	G;C;T	80;83;77	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1054	parC	2304	2304	98.31	parC.l15.c4.ctg.1	3179	98.9	0	.	p	.	0	A650T	NONSYN	1948	1950	GCA	2334	2336	ACA	97;97;96	A;C;A	73;80;76	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1054	parC	2304	2304	98.31	parC.l15.c4.ctg.1	3179	98.9	0	.	p	.	0	V660I	NONSYN	1978	1980	GTT	2364	2366	ATT	92;92;91	A;T;T	76;73;70	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1054	parC	2304	2304	98.31	parC.l15.c4.ctg.1	3179	98.9	0	.	p	.	0	M711L	NONSYN	2131	2133	ATG	2517	2519	CTG	98;97;96	C,A;T;G	77,1;82;77	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1054	parC	2304	2304	98.31	parC.l15.c4.ctg.1	3179	98.9	0	.	p	.	0	L738I	NONSYN	2212	2214	CTC	2598	2600	ATC	87;87;88	A,C;T;C	76,1;70;68	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1054	parC	2304	2304	98.31	parC.l15.c4.ctg.1	3179	98.9	0	.	p	.	0	A741S	NONSYN	2221	2223	GCC	2607	2609	TCC	89;90;90	T,G;C,G;C	69,1;73,1;76	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1054	parC	2304	2304	98.31	parC.l15.c4.ctg.1	3179	98.9	0	.	p	.	0	I743L	NONSYN	2227	2229	ATT	2613	2615	CTT	94;94;95	C,A;T;T	80,1;76;78	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1054	parC	2304	2304	98.31	parC.l15.c4.ctg.1	3179	98.9	0	.	p	.	0	R752K	NONSYN	2254	2256	AGA	2640	2642	AAA	99;99;98	A;A,G;A	80;78,1;80	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1054	parC	2304	2304	98.31	parC.l15.c4.ctg.1	3179	98.9	1	SNP	p	D86N	0	.	.	256	258	GAC	642	644	GAC	152;149;149	G,C;A;C	117,1;115;121	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1054	parC	2304	2304	98.31	parC.l15.c4.ctg.1	3179	98.9	1	SNP	p	S87I	0	.	.	259	261	AGT	645	647	AGT	147;148;147	A,T,C;G;T	114,1,1;122;118	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1054	parC	2304	2304	98.31	parC.l15.c4.ctg.1	3179	98.9	1	SNP	p	S87W	0	.	.	259	261	AGT	645	647	AGT	147;148;147	A,T,C;G;T	114,1,1;122;118	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1054	parC	2304	2304	98.31	parC.l15.c4.ctg.1	3179	98.9	1	SNP	p	S87R	0	.	.	259	261	AGT	645	647	AGT	147;148;147	A,T,C;G;T	114,1,1;122;118	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1054	parC	2304	2304	98.31	parC.l15.c4.ctg.1	3179	98.9	1	SNP	p	S88P	0	.	.	262	264	TCC	648	650	TCC	146;146;146	T;C,A,G;C	117;118,2,1;123	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	900	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3125	86.2	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1543	1545	TGC	111;109;110	T;G;C	86;85;83	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	900	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3125	86.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1753	1755	GGC	109;109;109	G;G;C	90;88;85	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	930	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2658	104.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1416	1418	GCA	129;129;128	G;C;A	99;99;99	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	930	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2658	104.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1419	1421	ATC	128;129;130	A;T,C;C	98;97,1;100	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	930	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2658	104.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1431	1433	GTG	129;128;127	G,A;T;G	104,1;101;103	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	930	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2658	104.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1431	1433	GTG	129;128;127	G,A;T;G	104,1;101;103	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	930	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2658	104.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1935	1937	ACC	122;123;125	A;C,T;C,A	102;101,1;111,1	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	930	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2658	104.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1989	1991	GCG	127;128;128	G;C;G	99;90;100	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	930	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2658	104.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1989	1991	GCG	127;128;128	G;C;G	99;90;100	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	930	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2658	104.5	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2112	2114	GGT	148;148;148	G;G;T	114;119;118	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	930	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2658	104.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2121	2123	GGC	148;148;148	G;G;C	112;118;114	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	930	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2658	104.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2139	2141	CCG	142;141;141	C,T;C,T;G,C	106,1;110,1;108,1	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1224	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3383	108.0	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1790	1792	CTG	95;95;96	C;T,G;G	72;66,1;72	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	584	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1974	87.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	602	602	C	87	C,T	68,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	680	porB1b	1047	1047	98.28	porB1b.l15.c4.ctg.1	2153	94.3	0	.	p	.	0	G38E	NONSYN	112	114	GGA	634	636	GAA	124;126;125	G;A;A	96;99;99	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	680	porB1b	1047	1047	98.28	porB1b.l15.c4.ctg.1	2153	94.3	0	.	p	.	0	K120D	NONSYN	358	360	AAG	880	882	GAC	107;107;107	G,A;A;C,G	94,1;89;90,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	680	porB1b	1047	1047	98.28	porB1b.l15.c4.ctg.1	2153	94.3	1	SNP	p	D121N	1	D121N	NONSYN	361	363	GAC	883	885	AAC	108;109;109	A,G,C;A;C	88,1,1;94;90	porB1b.WHO_Z_02266c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	680	porB1b	1047	1047	98.28	porB1b.l15.c4.ctg.1	2153	94.3	0	.	p	.	0	Q187R	NONSYN	559	561	CAA	1081	1083	CGA	137;138;140	C;G;A	108;108;107	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	680	porB1b	1047	1047	98.28	porB1b.l15.c4.ctg.1	2153	94.3	0	.	p	.	0	S189G	NONSYN	565	567	AGC	1087	1089	GGC	140;140;141	G;G;C	110;109;108	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	680	porB1b	1047	1047	98.28	porB1b.l15.c4.ctg.1	2153	94.3	0	.	p	.	0	N212G	NONSYN	634	636	AAT	1156	1158	GGT	148;147;146	G;G;T	123;120;123	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	680	porB1b	1047	1047	98.28	porB1b.l15.c4.ctg.1	2153	94.3	0	.	p	.	0	D213N	NONSYN	637	639	GAT	1159	1161	AAT	147;146;146	A;A;T	121;124;124	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	680	porB1b	1047	1047	98.28	porB1b.l15.c4.ctg.1	2153	94.3	0	.	p	.	0	T215S	NONSYN	643	645	ACT	1165	1167	TCT	146;147;147	T;C;T	120;123;124	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	680	porB1b	1047	1047	98.28	porB1b.l15.c4.ctg.1	2153	94.3	0	.	p	.	0	F222L	NONSYN	664	666	TTT	1186	1188	CTT	151;151;154	C;T;T	120;121;122	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	680	porB1b	1047	1047	98.28	porB1b.l15.c4.ctg.1	2153	94.3	0	.	p	.	0	D333E	NONSYN	997	999	GAC	1519	1521	GAA	166;166;167	G,A;A;A,C	137,1;139;141,1	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	2416	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5305	136.3	0	.	p	.	0	M671I	NONSYN	2011	2013	ATG	2542	2544	ATA	138;138;137	A;T;A,G	118;115;113,1	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	2416	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5305	136.3	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2188	2190	CAT	103;104;104	C;A;T,G	86;86;86,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	382	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1281	89.1	1	SNP	p	V57M	1	.	.	169	171	ATG	679	681	ATG	157;157;158	A;T;G	129;128;131	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
